Clin Osteol 2012; 17(2): 65-68

Serum homocysteine levels in children with fractures and low bone mineral density - a pilot studyOriginal contributions

Š. Kutílek, P. Řeháčková, V. Němec, E. Bočkayová

Background: High serum homocysteine (S-Hcy) levels are associated with low bone mineral density (BMD) and increased fracture risk in postmenopausal women. So far, data on S-Hcy and bone health are lacking in children and adolescents. Patients, Methods: We assessed S-Hcy levels in 19 children and adolescents (12 boys and 7 girls; mean age 14.9 ± 3.3 years) with pre­ valent low-energy trauma fractures (mean 4 ± 2.6 per patient) and/or low spinal L1-L4 BMD (below -2SD Z-score; DXA Lunar GE). Other assessments included serum alkaline phosphatase (S-ALP) and serum CrossLaps. At the time of assessment, the children were not taking any Z-scores ± SD.

Results: S-Hcy Z-score was significantly higher (1.4 ± 1.8; p = 0.001) and L1-L4 BMD Z-score was significantly lower (-2.1 ± 1.3; p = 0.0001), respectively, in comparison with reference values. S-ALP did not differ from reference values (p = 0.91), while S-CrossLaps were higher (1.5 ± 1.9; p = 0.001). S-Hcy was inversely correlated to L1-L4 BMD (r = -0.66; p = 0.01) and S-ALP (r = -0.56; p = 0.03) and not related to number of prevalent fractures (r = 0.11) or S-CrossLaps (r = -0.14). These results suggest negative influence of ele­ vated S-Hcy on bone formation and BMD in children with fractures, while bone resorption was increased in this group of pediatric pa­ tients. In conclusion, our results suggest that elevated S-Hcy is a risk facto Further studies are necessary for more detailed clarification of these issues.

Keywords: homocysteine, bone mineral density, fractures, bone turnover markers Address: Doc. MUDr. Štěpán Kutilek, CSc., Department of Pediatrics, Pardubi

Published: December 11, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kutílek Š, Řeháčková P, Němec V, Bočkayová E. Serum homocysteine levels in children with fractures and low bone mineral density - a pilot study. Osteologický bulletin. 2012;17(2):65-68.
Download citation

References

  1. Rauh M, Verwied S, Knerr I, Dorr HG, Sonnichsen A, Koletzko B. Homocysteine concentrations in a German cohort of 500 individuals: reference ranges and de­ terminants of pl 2001;20:409-418.
  2. Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J, Weg DACH-LIGA homocystein (german, austrian and swiss homocysteine society): Consensus paper on the rational clinical use of homocysteine, folic acid and B tamins in cardiovascular and thrombotic diseases: guidelines and recommendati­ ons. Clin Chem Lab Med 2003;41:1392-1403. Go to original source...
  3. Riddell LJ, Chisholm A, Duncan A, Mann JI. Homocysteine levels in he Zealanders and those with vascular disease. N Z Med J 1999;112:438-442.
  4. Bucciarelli P, Martini G, Martinelli I, Ceccarelli E, Gennari L, Bader R, Val R, Franci B, Nuti R, Mannucci PM. The relationship between plasma homocyste­ ine levels and bone mineral density in post-menopausal women. Eur J Intern Med 2010;21:301-305. Go to original source...
  5. Ouzzif Z, Oumghar K, Sbai K, Mounach A, Derouiche EM, Maghraoui A Relation of plasma total homocysteine, folate and vitamin B12 levels to bone mi­ neral density in Moroccan healthy postmenopausal women. Rheumatol Int 20102;32:123-128. Go to original source...
  6. Yilmaz N, Eren E. Homocysteine oxidative stress and relation to bone mineral density in post-menopausal osteoporosis. Aging Clin Exp Res 2009;21:353-357. Go to original source...
  7. Shiraki M, Shiraki Y, Tanaka S, Higuchi T, Saito M. Urinary pentosidine and plas­ ma homocysteine levels at baseline predict future fractures in osteoporosis p under bisphosphonate treatment. Bone Miner Metab 2011;29:62-70. Go to original source...
  8. Haliloglu B, Aksungar FB, Ilter E, Peker H, Akin FT, Mutlu N, Ozekici U. Relationship between bone mineral density, bone turnover markers and homocys­ teine, folate and vitamin B12 levels in postmenopausal women. Arch Gynecol Obstet 2010;281:663-668. Go to original source...
  9. Krivošíková Z, Krajčovičová-Kudláčková M, Spustová V, Štefíková K, Valachovicová M, Blažíček P, Němcová T. The association between high plasma homocysteine levels and lower bone mineral density in Slovak women: the of vegetarian diet. Eur J Nutr 2010;49:147-153. Go to original source...
  10. Levasseur R. Bone tissue and hyperhomocysteinemia. Joint Bone Spine 2009;76:234-240. Go to original source...
  11. Bozkurt N, Erdem M, Yilmaz E, Erdem A, Biri A, Kubatova A, Bozkurt M. The relationship of homocysteine, B12 and folic acid with the bone mineral density the femur and lumbar spine in Turkish postmenopausal women. Arch Gynecol Obstet 2009;280:381-387. Go to original source...
  12. Leboff MS, Narweker R, LaCroix A, Wu L, Jackson R, Lee J, Bauer DC, Cauley J, Kooperberg C, Lewis C, Thomas AM, Cummings S. Homocysteine levels and risk of hip fracture in postmenopausal women. J Clin Endocrinol Metab 2009;94:1207-1213. Go to original source...
  13. Claes L, Schmalenbach J, Herrmann M, Olku I, Garcia P, Histing T, Obeid R, Schorr H, Herrmann W, Pohlemann T, Menger MD, Holstein JH. Hyperhomocysteinemia is associated with impaired fracture healing in mice. Calcif Tissue Int 2009;85:17-21. Go to original source...
  14. Herrmann M, Tami A, Wildemann B, Wolny M, Wagner A, Schorr H, TabanShomal O, Umanskaya N, Ross S, Garcia P, Hubner U, Herrmann W. Hyperhomocysteinemia induces a tissue specific accumulation ofhomocysteine in bone by collagen binding and adversely affects bone. Bone 2009;44:467-475. Go to original source...
  15. Vaes BL, Lute C, Blom HJ, Bravenboer N, de Vries TJ, Everts V, DhonuksheRutten RA, Muller M, de Groot LC, Steegenga WT. Vitamin B(12) deficiency sti­ mulates osteoclastogenesis via increased homocysteine and methylmalonic acid. Calcif Tissue Int 2009;84:413^22. Go to original source...
  16. Kobzová J, Vignerová J, Bláha P, Krejčovský L, Riedlová J. The 6th nationwide anthropological survey of children and Cent Eur J Publ Health 2004;12:126-130.
  17. Němec V, Bočkayová E, Kutilek Š. Serum homocysteine and adolescents. Acta Medica 2012;55:accepted, in print. Go to original source...
  18. Kutilek Š, Bayer M. Hodnoty celkové aktivity alkalické fosfatázy v séru u děti v závislosti na věku a růstu (Total serum alkaline phosphatase activity and its lationship to age and growth in children). Osteol Bull 2003;8:52-55.
  19. Crofton PM, Evans N, Taylor MRH, Holland CV. Serum CrossLaps: Pediatric re­ ference intervals from birth to 19 years of age. Clin Chem 2002;48:671-673. Go to original source...




Clinical Osteology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.